| Screening | Baseline | 6 mos | 12 mos |
---|---|---|---|---|
Sociodemographic: (e.g., age, race/ethnicity, education, housing) | Â | X | Â | Â |
Primary Outcome Measures | ||||
 Viral Load through a blood draw | X |  | X | X |
Secondary Outcome Measures | ||||
 ART adherence (SRSI) [54] and the CleverCap (intervention group only) | X |  | X | X |
Additional Outcome Measures | ||||
 Quality of Life (PROMIS-29) [55] |  | X | X | X |
 HIV Symptom Index [56] |  | X | X | X |
 Engagement in HIV Care [57] |  |  |  |  |
Mediators | ||||
 The HIV Medication Taking Self-Efficacy Sale |  | X | X | X |
 Motivation and outcome expectancies of ART adherence are assessed as three separate dimensions: attitudes, norms, and behavioral intentions to adhere to ART medication [58] |  | X | X | X |
 Self-regulation skills, which include self-monitoring, goal setting, and enlistment of self-incentives/plans [59] |  | X | X | X |
 HIV-regulated Stigma [60] |  | X | X | X |
Moderators | ||||
 Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) [61] |  | X | X | X |
 Depression and Anxiety (Beck Symptom Inventory) [62] |  | X | X | X |